Report Cover

Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Growth (Status and Outlook) 2020-2025


According to this study, over the next five years the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market will register a 5.4%% CAGR in terms of revenue, the global market size will reach $ 8982.8 million by 2025, from $ 7291.8 million in 2019.  In particular, this report presents the global revenue market share of key companies in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics, covering the supply chain analysis, impact assessment to the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market size growth rate in several scenarios, and the measures to be undertaken by Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
    Oral Therapy
    Injectable Therapy

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
    Hospitals & Clinics
    Home Settings
    Ambulatory Surgical Centers (ASCs)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
    Astellas Inc.
    Johnson & Johnson
    Dendreon Corporation
    Bayer AG
    Sanofi S.A
    ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
    To study and analyze the global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
    To understand the structure of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market by identifying its various subsegments.
    Focuses on the key global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the size of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
    1.1 Market Introduction
    1.2 Research Objectives
    1.3 Years Considered
    1.4 Market Research Methodology
    1.5 Economic Indicators
    1.6 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2015-2025
        2.1.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size CAGR by Region
    2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Segment by Type
        2.2.1 Oral Therapy
        2.2.2 Oral Therapy
    2.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
        2.3.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020)
        2.3.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Type (2015-2020)
    2.4 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Segment by Application
        2.4.1 Hospitals & Clinics
        2.4.2 Home Settings
        2.4.3 Ambulatory Surgical Centers (ASCs)
    2.5 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
        2.5.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020)
        2.5.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Application (2015-2020)

3 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Players
    3.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Players
        3.1.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Players (2018-2020)
        3.1.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Players (2018-2020)
    3.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Regions
    4.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions
    4.2 Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth
    4.3 APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth
    4.4 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth
    4.5 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth

5 Americas
    5.1 Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Countries
    5.2 Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
    5.3 Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Key Economic Indicators of Few Americas Countries

6 APAC
    6.1 APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions
    6.2 APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
    6.3 APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 Key Economic Indicators of Few APAC Regions

7 Europe
    7.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Countries
    7.2 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
    7.3 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
    7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
    8.1 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics by Countries
    8.2 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
    8.3 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Forecast
    10.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast (2021-2025)
    10.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by Regions
        10.2.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by Regions (2021-2025)
        10.2.2 Americas Market Forecast
        10.2.3 APAC Market Forecast
        10.2.4 Europe Market Forecast
        10.2.5 Middle East & Africa Market Forecast
    10.3 Americas Forecast by Countries
        10.3.1 United States Market Forecast
        10.3.2 Canada Market Forecast
        10.3.3 Mexico Market Forecast
        10.3.4 Brazil Market Forecast
    10.4 APAC Forecast by Countries
        10.4.1 China Market Forecast
        10.4.2 Japan Market Forecast
        10.4.3 Korea Market Forecast
        10.4.4 Southeast Asia Market Forecast
        10.4.5 India Market Forecast
        10.4.6 Australia Market Forecast
    10.5 Europe Forecast by Countries
        10.5.1 Germany Market Forecast
        10.5.2 France Market Forecast
        10.5.3 UK Market Forecast
        10.5.4 Italy Market Forecast
        10.5.5 Russia Market Forecast
        10.5.6 Spain Market Forecast
    10.6 Middle East & Africa Forecast by Countries
        10.6.1 Egypt Market Forecast
        10.6.2 South Africa Market Forecast
        10.6.3 Israel Market Forecast
        10.6.4 Turkey Market Forecast
        10.6.5 GCC Countries Market Forecast
    10.7 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by Type
    10.8 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecast by Application

11 Key Players Analysis
    11.1 Astellas Inc.
        11.1.1 Company Details
        11.1.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
        11.1.3 Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
        11.1.4 Main Business Overview
        11.1.5 Astellas Inc. News
    11.2 Johnson & Johnson
        11.2.1 Company Details
        11.2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
        11.2.3 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
        11.2.4 Main Business Overview
        11.2.5 Johnson & Johnson News
    11.3 Dendreon Corporation
        11.3.1 Company Details
        11.3.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
        11.3.3 Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
        11.3.4 Main Business Overview
        11.3.5 Dendreon Corporation News
    11.4 Bayer AG
        11.4.1 Company Details
        11.4.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
        11.4.3 Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
        11.4.4 Main Business Overview
        11.4.5 Bayer AG News
    11.5 Sanofi S.A
        11.5.1 Company Details
        11.5.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered
        11.5.3 Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue, Gross Margin and Market Share (2018-2020)
        11.5.4 Main Business Overview
        11.5.5 Sanofi S.A News
    ...

12 Research Findings and Conclusion

List of Tables Table 1. Research Methodology Table 2. Data Source Table 3. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size CAGR by Region 2015-2025 ($ Millions) Table 4. Major Players of Oral Therapy Table 5. Major Players of Injectable Therapy Table 6. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2014-2019) ($ Millions) Table 7. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020) Table 8. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) ($ Millions) Table 9. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020) Table 10. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue by Players (2018-2020) ($ Millions) Table 11. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Players (2018-2020) Table 12. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players Head office and Products Offered Table 13. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2018-2020) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions 2015-2020 ($ Millions) Table 17. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Regions 2015-2020 Table 18. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Countries (2015-2020) ($ Millions) Table 19. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries (2015-2020) Table 20. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) ($ Millions) Table 21. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020) Table 22. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) ($ Millions) Table 23. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020) Table 24. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions (2015-2020) ($ Millions) Table 25. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Regions (2015-2020) Table 26. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) ($ Millions) Table 27. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020) Table 28. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) ($ Millions) Table 29. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020) Table 30. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Countries (2015-2020) ($ Millions) Table 31. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries (2015-2020) Table 32. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) ($ Millions) Table 33. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020) Table 34. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) ($ Millions) Table 35. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020) Table 36. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Countries (2015-2020) ($ Millions) Table 37. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries (2015-2020) Table 38. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2015-2020) ($ Millions) Table 39. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020) Table 40. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2015-2020) ($ Millions) Table 41. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application (2015-2020) Table 42. Key and Potential Regions of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Table 43. Key Application and Potential Industries of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Table 44. Key Challenges of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Table 45. Key Trends of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Table 46. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast by Regions (2021-2025) ($ Millions) Table 47. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share Forecast by Regions Table 48. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast by Type (2021-2025) ($ Millions) Table 49. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share Forecast by Type (2021-2025) Table 50. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Forecast by Application (2021-2025) ($ Millions) Table 51. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share Forecast by Application (2021-2025) Table 52. Astellas Inc. Details, Company Total Revenue (in $ million), Head Office, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Major Market Areas and Its Competitors Table 53. Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered Table 54. Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Gross Margin (2018-2020E) Table 55. Astellas Inc. Main Business Table 56. Astellas Inc. Latest Developments Table 57. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Major Market Areas and Its Competitors Table 58. Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered Table 59. Johnson & Johnson Main Business Table 60. Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Gross Margin (2018-2020E) Table 61. Johnson & Johnson Latest Developments Table 62. Dendreon Corporation Details, Company Total Revenue (in $ million), Head Office, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Major Market Areas and Its Competitors Table 63. Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered Table 64. Dendreon Corporation Main Business Table 65. Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Gross Margin (2018-2020E) Table 66. Dendreon Corporation Latest Developments Table 67. Bayer AG Details, Company Total Revenue (in $ million), Head Office, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Major Market Areas and Its Competitors Table 68. Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered Table 69. Bayer AG Main Business Table 70. Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Gross Margin (2018-2020E) Table 71. Bayer AG Latest Developments Table 72. Sanofi S.A Details, Company Total Revenue (in $ million), Head Office, Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Major Market Areas and Its Competitors Table 73. Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Offered Table 74. Sanofi S.A Main Business Table 75. Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue and Gross Margin (2018-2020E) Table 76. Sanofi S.A Latest Developments List of Figures Figure 1. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Report Years Considered Figure 2. Market Research Methodology Figure 3. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate 2015-2025 ($ Millions) Figure 4. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type (2015-2020) Figure 5. Global Oral Therapy Market Size Growth Rate Figure 6. Global Injectable Therapy Market Size Growth Rate Figure 7. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Hospitals & Clinics Figure 8. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market: Hospitals & Clinics (2015-2020) ($ Millions) Figure 9. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Home Settings Figure 10. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market: Home Settings (2015-2020) ($ Millions) Figure 11. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Ambulatory Surgical Centers (ASCs) Figure 12. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market: Ambulatory Surgical Centers (ASCs) (2015-2020) ($ Millions) Figure 13. Global Ambulatory Surgical Centers (ASCs) YoY Growth ($ Millions) Figure 14. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application in 2019 Figure 15. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Regions 2015-2020 Figure 16. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2015-2020 ($ Millions) Figure 17. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2015-2020 ($ Millions) Figure 18. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2015-2020 ($ Millions) Figure 19. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2015-2020 ($ Millions) Figure 20. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries in 2019 Figure 21. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type in 2019 Figure 22. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application in 2019 Figure 23. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 24. Canada Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 25. Mexico Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 26. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Regions in 2019 Figure 27. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type in 2019 Figure 28. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application in 2019 Figure 29. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 30. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 31. Korea Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 32. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 33. India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 34. Australia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 35. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries in 2019 Figure 36. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type in 2019 Figure 37. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application in 2019 Figure 38. Germany Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 39. France Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 40. UK Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 41. Italy Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 42. Russia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 43. Spain Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 44. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Countries in 2019 Figure 45. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Type in 2019 Figure 46. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Market Share by Application in 2019 Figure 47. Egypt Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 48. South Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 49. Israel Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 50. Turkey Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 51. GCC Countries Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth 2015-2020 ($ Millions) Figure 52. Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics arket Size Forecast (2021-2025) ($ Millions) Figure 53. Americas Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 54. APAC Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 55. Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 56. Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 57. United States Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 58. Canada Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 59. Mexico Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 60. Brazil Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 61. China Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 62. Japan Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 63. Korea Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 64. Southeast Asia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 65. India Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 66. Australia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 67. Germany Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 68. France Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 69. UK Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 70. Italy Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 71. Russia Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 72. Spain Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 73. Egypt Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 74. South Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 75. Israel Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 76. Turkey Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions) Figure 77. GCC Countries Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size 2021-2025 ($ Millions)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us